A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® received MHRA approval for both subcutaneous and intravenous formulations, to ...

Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing MENLO PARK, ...

Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc’s blockbuster Tagrisso in a ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

wherein its nuclear translocation increases NF-κB activity promoting resistance to platinum-based chemotherapy in colorectal cancer.

Yet, initial treatment of AHF today is similar to 40 years ago. Multiple studies have yielded new insights regarding initial management, with regards to both treatment and strategies of care.

That’s where bread machines save the day. Many bread machines can mix, proof and bake all in one go, making it easy to get fresh bread without the hassle. It’s compact, too, so there’s less ...

Hurricane Helene brought unprecedented and catastrophic flooding to western North Carolina, damaging a Baxter manufacturing site that was a major supplier of IV fluids. Hospitals across the country ...

Researchers have developed tests to predict who might benefit from having chemotherapy. Prosigna is one of these tests. The Prosigna test uses a specialist machine to look at a sample of cancer tissue ...

HARRISBURG, Pa. (AP) — A Pennsylvania court on Tuesday ruled 6-1 that the secretary of state has the authority to direct counties not to allow “unauthorized third party access” to voting machines or ...